
Lixiao Zhang
Articles
-
Aug 15, 2024 |
pubs.acs.org | Qiuyue Zhang |Lixiao Zhang |Jia Yu |Zeyu Han
-
Jan 8, 2024 |
future-science.com | Qiuyue Zhang |Yuxuan Zhang |Lixiao Zhang |Jia Yu
Background: Specifically blocking HSP90–CDC37 interaction is emerging as a prospective strategy for cancer therapy. Aim: Applying a kinase pseudopeptide rationale to the discovery of HSP90–CDC37 protein–protein interaction (PPI) inhibitors. Methods: Pseudosubstrates were identified through sequence alignment and evaluated by biolayer interferometry assay, co-immunoprecipitation assay and antiproliferation assay.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →